ERSP
This article was originally published in The Rose Sheet
Executive Summary
Electronic Retailing Self-Regulation Program determines product testing of Hydroderm Body Shape Cellulite Reducing lotion provides a "reasonable basis" for general performance claims communicated in Internet and print ads, the National Advertising Review Council division announces. Hydroderm's double-blinded, controlled studies employed reliable measurement techniques to support claims the product improves the appearance of cellulite and skin tone, group concludes. ERSP also determines firm provided a reasonable basis for claims that Body Shape utilizes a patent pending liposome delivery system that transports ingredients through the skin and into fat cells. However, Hydroderm will discontinue certain establishment and performance claims, firm says, noting the decision is unrelated to the inquiry...